Cas no 154801-30-6 (2-Hydroxy-N-(1,3,4-trihydroxyoctadecan-2-yl)tetracosanamide)
2-Hydroxy-N-(1,3,4-trihydroxyoctadecan-2-yl)tetracosanamide Chemical and Physical Properties
Names and Identifiers
-
- 2-Hydroxy-N-(1,3,4-trihydroxyoctadecan-2-yl)tetracosanamide
- 2-(2'-Hydroxytetracosanoylamino)- octadecane-1,3,4-triol
- 2-(2'-Hydroxytetracosanoylamino)
- 2-(2'-Hydroxytetracosanoylamino)-octadecane-1,3,4-triol
- Tetracosanamide,N-[(1S,2S,3R)-2,3-dihydroxy-1-(hydroxymethyl)heptadecyl]-2-hydroxy-, (2R)-
- (2S,3S,4R)-2-[(2'R)-2'-hydroxytetracosanoylamino]-1,3,4-octadecanetriol
- (2S,3S,4R,2'R)-2-(2'-Hydroxytetracosanoylamino)-octadecane-1,3,4-triol
- Tetracosanamide,N-[2,3-dihydroxy-1-(hydroxymethyl)heptadecyl]-2-hydroxy-,[1S-[1R*(S*),2R*,3S*]]-
- Russulaceramide
- [ "Russulaceramide" ]
- 2-(2'-Hydroxytetracosaylami)- octadecane-1,3,4-triol
- 2-(2?-Hydroxytetracosanoylamino)-octadecane-1?3?4-triol
- 154801-30-6
- 2-(2/'-Hydroxytetracosaylami)-octadecane-1,3,4-triol
- A883698
- N-[2,3-Dihydroxy-1-(hydroxymethyl)heptadecyl]-2-hydroxytetracosanamide
- PD071073
- 2433-99-0
- Cer 18:0;3O/24:0;(2OH)
- AKOS022184631
- SCHEMBL4135907
- DTXSID901154362
- N-(2R-hydroxytetracosanoyl)-4R-hydroxyl-octadecasphinganine
- (2S,3S,4R,2'R)-2-(2'-Hydroxytetracosanoylamino)-octadecane-1,3,4-triol, (+)-
- (2S, 3S, 4R)-2-[(2R)-2-hydroxytetracosanoylamino]-1, 3, 4-octadecanetriol
- Cer(t18:0/24:0(2OH[R]))
- N-24:0(2R-OH) Phytosphingosine, N-(2'-(R)-hydroxylignoceroyl)-phytosphingosine (Saccharomyces Cerevisiae), powder
- CHEBI:226309
- (2R)-2-hydroxy-N-[(2S,3S,4R)-1,3,4-trihydroxyoctadecan-2-yl]tetracosanamide
- N-(2R-hydroxytetracosanoyl)-phytoceramide
- (2R)-N-[(1S,2S,3R)-2,3-dihydroxy-1-(hydroxymethyl)heptadecyl]-2-hydroxy-tetracosanamide
- N-(2R-hydroxytetracosanoyl)-4R-hydroxysphinganine
- Cer(t18:0)/24:0(2OH[R]))
- Tetracosanamide, N-((1S,2S,3R)-2,3-dihydroxy-1-(hydroxymethyl)heptadecyl)-2-hydroxy-, (2R)-
- PD071072
- (2S,3S,4R)-2-((2'R)-2'-Hydroxytetracosanoylamino)-1,3,4-octadecanetriol
- 2-(2'-Hydroxytetracosanoylamino)-octadecane-1,3,4-triol, (2S,3S,4R,2'R)-
- CS-0103738
- HY-N7158
- FS-10418
- LMSP02030026
- Elasticamide
- AKOS040760971
- WCK3J2NNE4
- UNII-WCK3J2NNE4
- DTXSID701152146
- 2-(2'-Hydroxytetracosaylami)-
- (2S,3S,4R)-2-[(2a(2)R)-2a(2)-hydroxytetracosanoylamino]-1,3,4-octadecanetriol
-
- Inchi: 1S/C42H85NO5/c1-3-5-7-9-11-13-15-17-18-19-20-21-22-23-24-26-28-30-32-34-36-40(46)42(48)43-38(37-44)41(47)39(45)35-33-31-29-27-25-16-14-12-10-8-6-4-2/h38-41,44-47H,3-37H2,1-2H3,(H,43,48)/t38-,39+,40+,41-/m0/s1
- InChI Key: ZFUXWVVVWGWGPQ-QLLOZFISSA-N
- SMILES: O[C@H](CCCCCCCCCCCCCC)[C@H]([C@H](CO)NC([C@@H](CCCCCCCCCCCCCCCCCCCCCC)O)=O)O
Computed Properties
- Exact Mass: 683.64300
- Monoisotopic Mass: 683.64277481g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 5
- Hydrogen Bond Acceptor Count: 5
- Heavy Atom Count: 48
- Rotatable Bond Count: 39
- Complexity: 648
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 4
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 15.8
- Topological Polar Surface Area: 110?2
Experimental Properties
- Color/Form: Powder
- Density: 1.0±0.1 g/cm3
- Boiling Point: 799.3±60.0 °C at 760 mmHg
- Flash Point: 437.2±32.9 °C
- PSA: 110.02000
- LogP: 11.24030
- Vapor Pressure: 0.0±6.4 mmHg at 25°C
2-Hydroxy-N-(1,3,4-trihydroxyoctadecan-2-yl)tetracosanamide Security Information
- Hazard Statement: H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
- Warning Statement: P264+P280+P305+P351+P338+P337+P313
- Hazardous Material transportation number:NONH for all modes of transport
- Safety Instruction: H303+H313+H333
- Storage Condition:?20°C
2-Hydroxy-N-(1,3,4-trihydroxyoctadecan-2-yl)tetracosanamide Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | TN2681-1 mg |
Elasticamide |
154801-30-6 | 1mg |
¥2035.00 | 2022-04-26 | ||
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | H64640-5mg |
2-(2'-Hydroxytetracosanoylamino)-octadecane-1,3,4-triol |
154801-30-6 | ,HPLC≥96.0% | 5mg |
¥4000.0 | 2023-09-07 | |
| SHANG HAI TAO SHU Biotechnology Co., Ltd. | TN2681-1 mg |
2-(2'-Hydroxytetracosanoylamino)-octadecane-1,3,4-triol |
154801-30-6 | 1mg |
¥2035.00 | 2021-09-23 | ||
| XI GE MA AO DE LI QI ( SHANG HAI ) MAO YI Co., Ltd. | 860924P-5MG |
2-Hydroxy-N-(1,3,4-trihydroxyoctadecan-2-yl)tetracosanamide |
154801-30-6 | 5mg |
¥3207.51 | 2023-11-02 | ||
| Ambeed | A468453-5mg |
(R)-2-Hydroxy-N-((2S,3S,4R)-1,3,4-trihydroxyoctadecan-2-yl)tetracosanamide |
154801-30-6 | 98+% | 5mg |
$222.0 | 2025-02-20 | |
| TargetMol Chemicals | TN2681-5 mg |
Elasticamide |
154801-30-6 | 98% | 5mg |
¥ 2,760 | 2023-07-11 | |
| TargetMol Chemicals | TN2681-1 mL * 10 mM (in DMSO) |
Elasticamide |
154801-30-6 | 98% | 1 mL * 10 mM (in DMSO) |
¥ 4230 | 2023-09-15 | |
| TargetMol Chemicals | TN2681-5mg |
Elasticamide |
154801-30-6 | 5mg |
¥ 33800 | 2024-07-20 | ||
| Aaron | AR00ALK0-5mg |
2-(2'-Hydroxytetracosaylami)-
octadecane-1,3,4-triol |
154801-30-6 | 5mg |
$561.00 | 2025-02-13 | ||
| 1PlusChem | 1P00ALBO-1mg |
2-(2'-Hydroxytetracosaylami)-
octadecane-1,3,4-triol |
154801-30-6 | ≥98% | 1mg |
$409.00 | 2024-06-20 |
2-Hydroxy-N-(1,3,4-trihydroxyoctadecan-2-yl)tetracosanamide Suppliers
2-Hydroxy-N-(1,3,4-trihydroxyoctadecan-2-yl)tetracosanamide Related Literature
-
J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
-
Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
-
Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
-
Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
Additional information on 2-Hydroxy-N-(1,3,4-trihydroxyoctadecan-2-yl)tetracosanamide
Comprehensive Overview of 2-Hydroxy-N-(1,3,4-trihydroxyoctadecan-2-yl)tetracosanamide (CAS No. 154801-30-6)
2-Hydroxy-N-(1,3,4-trihydroxyoctadecan-2-yl)tetracosanamide, with the CAS number 154801-30-6, is a specialized amphiphilic compound that has garnered significant attention in the fields of biochemistry, pharmaceuticals, and cosmetic science. This molecule, characterized by its unique hydroxy fatty acid and long-chain amide structure, exhibits remarkable properties that make it a subject of ongoing research. Its multi-hydroxyl groups contribute to its hydrophilic nature, while the tetracosanamide tail ensures lipophilic compatibility, making it an excellent candidate for lipid-based drug delivery systems and skincare formulations.
In recent years, the demand for natural-derived bioactive compounds has surged, driven by consumer preferences for sustainable and eco-friendly ingredients. 2-Hydroxy-N-(1,3,4-trihydroxyoctadecan-2-yl)tetracosanamide aligns perfectly with this trend, as it is often sourced from natural lipids or synthesized via green chemistry approaches. Researchers are particularly interested in its potential applications in anti-aging creams, moisturizers, and barrier repair products, where its ability to enhance skin hydration and elasticity has been preliminarily validated.
The compound's CAS no154801-30-6 is frequently searched in academic databases and patent repositories, reflecting its growing relevance in cutting-edge research. One of the most common queries revolves around its mechanism of action in cellular membranes. Studies suggest that its hydrophilic-lipophilic balance (HLB) enables it to integrate seamlessly into lipid bilayers, potentially modulating membrane fluidity and signaling pathways. This property has sparked interest in its use for targeted drug delivery, particularly in treating dermatological conditions and metabolic disorders.
Another hot topic linked to 2-Hydroxy-N-(1,3,4-trihydroxyoctadecan-2-yl)tetracosanamide is its role in biodegradable nanomaterials. With the rise of nanotechnology in medicine, this compound's ability to self-assemble into micelles or vesicles offers promising avenues for non-toxic carrier systems. Its compatibility with biopolymers like chitosan and hyaluronic acid further expands its utility in tissue engineering and wound healing applications.
From an industrial perspective, scalability and cost-effective synthesis of CAS no154801-30-6 remain critical challenges. Innovations in enzymatic catalysis and fermentation technology are being explored to address these hurdles. Additionally, regulatory compliance for its use in cosmeceuticals and nutraceuticals is a frequent discussion point, with emphasis on safety profiles and ecotoxicology assessments.
In conclusion, 2-Hydroxy-N-(1,3,4-trihydroxyoctadecan-2-yl)tetracosanamide (CAS No. 154801-30-6) represents a versatile and scientifically intriguing compound with broad potential across multiple industries. Its dual affinity for water and lipids, combined with its bioactive hydroxyl groups, positions it as a key player in the future of personalized medicine and sustainable cosmetics. As research progresses, this molecule is poised to answer pressing questions in material science and therapeutic innovation.
154801-30-6 (2-Hydroxy-N-(1,3,4-trihydroxyoctadecan-2-yl)tetracosanamide) Related Products
- 923012-45-7(Docosanamide,N-[2,3-dihydroxy-1-(hydroxymethyl)heptadecyl]-2-hydroxy-)
- 2433-99-0(Tetracosanamide,N-[2,3-dihydroxy-1-(hydroxymethyl)heptadecyl]-2-hydroxy-)
- 128802-67-5((2S,3S,4R)-2-((R)-2-Hydroxytetracosanoylamino)-1,3,4-hexadecanetriol)
- 37211-11-3(Phrenosin)
- 1314867-94-1((2R)-N-[(1S,2S,3R)-2,3-dihydroxy-1-(hydroxymethyl)tricosyl]-2-hydroxyoctadecanamide)
- 1354701-96-4((2S,3S,4R,2'R)-2-(2'-hydroxytricosanoylamino)nonadecane-1,3,4-triol)
- 373381-39-6(Docosanamide,N-[(1S,2S,3R)-2,3-dihydroxy-1-(hydroxymethyl)heptadecyl]-2-hydroxy-)
- 164988-96-9(Hexacosanamide,N-[(1S,2S,3R)-2,3-dihydroxy-1-(hydroxymethyl)heptadecyl]-2-hydroxy-,(2R)-)
- 1258064-77-5((2S,3S,4R)-2-[(2R)-2-hydroxypentacosanoylamino]nonacosane-1,3,4-triol)
- 212070-46-7(Tetracosanamide,N-[(1S,2S,3R)-2,3-dihydroxy-1-(hydroxymethyl)heptadecyl]-2-hydroxy-)